托拉塞米联合甘露醇治疗急性脑出血患者对脑水肿、颅内血肿体积的影响(1)
【摘要】目的 讨托拉塞米联合甘露醇治疗急性脑出血患者对脑水肿、颅内血肿体积的影响。方法 选择2016年3月至2017年3月在我院治疗的急性脑出血患者50例,按用药不同将患者分为25例对照组(给予甘露醇治疗)与25例观察组(给予托拉塞米联合甘露醇治疗)。比较两组治疗后脑水肿和颅内血肿体积。结果 观察组治疗后脑水肿体积为(13.85±7.43)ml,小于对照组的(20.71±10.08)ml,差异有统计学意义(P<0.05);观察组治疗后颅内血肿体积为(24.01±6.52)ml,小于对照组的(28.14±7.70)ml,差异有统计学意义(P<0.05)。结论 拉塞米联合甘露醇治疗急性脑出血患者可有效抑制脑水肿,同时能预防颅内高压,从而加快患者神经功能恢复。【关键词】急性脑出血;托拉塞米;甘露醇;脑水肿;颅内血肿
【中图分类号】R742.7 【文献标识码】A 【文章编号】ISSN.2095-6681.2017.20..02
【Abstract】Objective To evaluate the effect of roxocamidine combined with mannitol on brain edema and intracranial hematoma volume in patients with acute cerebral hemorrhage.Methods Fifty patients with acute cerebral hemorrhage treated in our hospital from March 2000 to May 2017 were divided into 25 control groups (treated with mannitol) and 25 patients(given Tora M combined mannitol treatment).Brain edema and intracranial hematoma volume were compared between the two groups.Results The volume of brain edema in the observation group was (13.85 ±7.43)ml ......
您现在查看是摘要页,全文长 3325 字符。